Showing 1831-1840 of 3695 results for "".
Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/New Products and Devices
https://practicaldermatology.com/columns/new-products/new-products-and-devices/20567/New products and pharmacologic developments• Cosmetic Eyeliner Tattoo Complications
• Morphea After Endovenous Cyanoacrylate Adhesive Embolizationhttps://practicaldermatology.com/youngmd-connect/resident-resource-center/bull-cosmetic-eyeliner-tattoo-complicationsbrbull-morphea-after-endovenous-cyanoacrylate-adhesive-embolization/23771/For Now, the No Surprises Act Applies to All Providers
https://practicaldermatology.com/topics/practice-management/for-now-the-no-surprises-act-applies-to-all-providers/23780/It seems that dermatologists and others providing aesthetic services must comply with new legislation.The Road Map to Success: When Does it Make Sense to Have a Dermatology PA?
https://practicaldermatology.com/topics/practice-management/the-road-map-to-success-when-does-it-make-sense-to-have-a-dermatology-pa/23235/Adding a new provider can increase access and boost the bottom line. But how do you choose?Currents: Cosmetic Dermatology Updates
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-cosmetic-dermatology-updates/23848/Currents: Best Face Forward
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-best-face-forward/23190/Updates on Aesthetic Trends and Practice Strategies for 2020Currents: Skin of Color
https://practicaldermatology.com/topics/skin-of-color/currents-1/22985/Case Report: Minimal Incision Extraction for Large Lipomas
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-minimal-incision-extraction-for-large-lipomas/21189/Protect or Defend: Sorting Through Oral Supplement Claims
https://practicaldermatology.com/topics/skin-cancer-photoprotection/protect-or-defend-sorting-through-oral-supplement-claims/20470/A recent FDA action calls attention to unfounded claims, but it may create some confusion.